Change in albuminuria and subsequent risk of end-stage kidney disease : an individual participant-level consortium meta-analysis of observational studies
Citation
Coresh , J , Heerspink , H J L , Sang , Y , Matsushita , K , Arnlov , J , Astor , B C , Black , C , Brunskill , N J , Carrero , J-J , Feldman , H I , Fox , C S , Inker , L A , Ishani , A , Ito , S , Jassal , S , Konta , T , Polkinghorne , K , Romundstad , S , Solbu , M D , Stempniewicz , N , Stengel , B , Tonelli , M , Umesawa , M , Waikar , S S , Wen , C-P , Wetzels , J F M , Woodward , M , Grams , M E , Kovesdy , C P , Levey , A S , Gansevoort , R T & Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration 2019 , ' Change in albuminuria and subsequent risk of end-stage kidney disease : an individual participant-level consortium meta-analysis of observational studies ' , The lancet. Diabetes & endocrinology , vol. 7 , no. 2 , pp. 115-127 . https://doi.org/10.1016/S2213-8587(18)30313-9
URI
http://hdl.handle.net/2164/12518http://www.scopus.com/inward/record.url?scp=85060314551&partnerID=8YFLogxK
Rights
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/